Butasal vet Stungulyf, lausn 100+0,05 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

butasal vet stungulyf, lausn 100+0,05 mg/ml

interchemie werken de adelaar eesti as - butafosfan; cyanocobalaminum inn - stungulyf, lausn - 100+0,05 mg/ml

Exagon vet. (Exagon 400) Stungulyf, lausn 400 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

exagon vet. (exagon 400) stungulyf, lausn 400 mg/ml

vetviva richter gmbh - pentobarbitalum natríum - stungulyf, lausn - 400 mg/ml

Procamidor vet. Stungulyf, lausn 20 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

procamidor vet. stungulyf, lausn 20 mg/ml

vetviva richter gmbh - procainum hýdróklóríð - stungulyf, lausn - 20 mg/ml

Spasmium vet. (Spasmium compositum vet.) Stungulyf, lausn 500 mg/ml + 4 mg ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

spasmium vet. (spasmium compositum vet.) stungulyf, lausn 500 mg/ml + 4 mg ml

vetviva richter gmbh - metamizolum natricum inn; butylscopolamini bromidum nfn - stungulyf, lausn - 500 mg/ml + 4 mg ml

Vetrimoxin L.A. Stungulyf, dreifa 150 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

vetrimoxin l.a. stungulyf, dreifa 150 mg/ml

ceva santé animale* - amoxicillinum tríhýdrat - stungulyf, dreifa - 150 mg/ml

Porcilis Pesti Evrópusambandið - íslenska - EMA (European Medicines Agency)

porcilis pesti

intervet international bv - classical swine fever virus (csfv) -e2 undireiningu mótefnavaka - Ónæmissjúkdómar fyrir suidae - svín - virkt ónæmisaðgerðir svín frá 5 vikna aldri til að koma í veg fyrir dauðsföll og draga úr klínískum einkennum á klassískum svínakjöti, auk þess að draga úr sýkingu við og útskilnað á csf sviði veira. upphaf verndar er 2 vikur. verndartími er 6 mánuðir.

Albuman Innrennslislyf, lausn 200 g/l Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

albuman innrennslislyf, lausn 200 g/l

prothya biosolutions netherlands b.v. - human serum albumin - innrennslislyf, lausn - 200 g/l

Alburex Innrennslislyf, lausn 200 g/l Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

alburex innrennslislyf, lausn 200 g/l

csl behring gmbh* - human albumin - innrennslislyf, lausn - 200 g/l

Flebogamma DIF (previously Flebogammadif) Evrópusambandið - íslenska - EMA (European Medicines Agency)

flebogamma dif (previously flebogammadif)

instituto grifols s.a. - mönnum eðlilegt að notkun - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - Ónæmiskerfið sera og mótefni, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.

Combisyn Stungulyf, dreifa 14,0/3,5 % w/v Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

combisyn stungulyf, dreifa 14,0/3,5 % w/v

norbrook laboratories (ireland) limited - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - stungulyf, dreifa - 14,0/3,5 % w/v